Diligence memo · auto-generated · as of July 3, 2026

Life Biosciences LLC

Life Biosciences LLC has raised $123M over 2 rounds; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Life Biosciences LLC operates in Biotech / Pharma, based in BOSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Life Biosciences LLC has raised $123M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $75M on 2020-05-29.

Most recent recorded round closed around 2020-05-29.

Valuation (modeled)modeled

Provath models Life Biosciences LLC at approximately $2.8B (range $237M–$7.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 6.1 yr ago; this sector typically re-raises about every 15 months.

Silent for over 3× the sector's normal cadence.

The last round was 4.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 95% of Biotech / Pharma peers (227 compared).

Modeled value ranks above 99% of those peers.

Closest niche peers: Imago BioSciences, Inc., BlueSphere Bio, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.